United Therapeutics Corporation

URI: https://gptkb.org/entity/United_Therapeutics_Corporation
GPTKB entity
Statements (29)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:CEO gptkb:Martine_Rothblatt
gptkbp:countryOfOperation gptkb:United_States
gptkbp:focusesOn oncology
pulmonary arterial hypertension
organ manufacturing
gptkbp:foundedBy gptkb:Martine_Rothblatt
gptkbp:foundedYear 1996
gptkbp:headquartersLocation gptkb:Silver_Spring,_Maryland,_United_States
https://www.w3.org/2000/01/rdf-schema#label United Therapeutics Corporation
gptkbp:industry gptkb:biotechnology
gptkbp:netIncome $656 million (2023)
gptkbp:notableAchievement first FDA-approved treatment for pediatric neuroblastoma (Unituxin)
pioneering organ manufacturing and transplantation technologies
gptkbp:numberOfEmployees ~1000
gptkbp:product gptkb:Adcirca
gptkb:Orenitram
gptkb:Remodulin
gptkb:Tyvaso
gptkb:Unituxin
gptkbp:publiclyTraded true
gptkbp:revenue $2.1 billion (2023)
gptkbp:stockExchange gptkb:NASDAQ_Biotechnology_Index
gptkbp:stockSymbol gptkb:UTHR
gptkbp:subsidiary gptkb:Lung_Biotechnology_PBC
gptkbp:tradedOn NASDAQ: UTHR
gptkbp:website https://www.unither.com/
gptkbp:bfsParent gptkb:United_Therapeutics_headquarters
gptkbp:bfsLayer 7